Baidu
map
J NEUROINTERV SURG 润色咨询

Journal of NeuroInterventional Surgery

出版年份:2009 年文章数:1864 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:20.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2220554, encodeId=13ae2220554e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审稿很快,一个月左右一审回来,返修格式问题耽误了几天,返修后3天左右录用,版面费3.5w,也可以选择非OA。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Aug 16 16:36:07 CST 2024, time=2024-08-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:磁共振;介入;斑块<br>经验分享:技术问题当天回复 一个月内给修改意见 返修以后一周内给结果 proof后4天就在线发表了 不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚见刊,今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快,格式上问题转天就通知修改。杂志偏向介入外科、技术方向,跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回 (专硕临床忙没时间修改到最后截止时间) 5.31 Accept 4个 审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗?<span class="quote">HawkingS 2016-12-14 发表::<br>研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span><span class="quote">HawkingS 2016-12-14 16:34:00 发表:<br>2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天,接收后约15天online<span class="quote">HawkingS 2016-12-14 发表::<br>接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2024-08-16 N.Yan 来自天津

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:审稿很快,一个月左右一审回来,返修格式问题耽误了几天,返修后3天左右录用,版面费3.5w,也可以选择非OA。

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2220554, encodeId=13ae2220554e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审稿很快,一个月左右一审回来,返修格式问题耽误了几天,返修后3天左右录用,版面费3.5w,也可以选择非OA。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Aug 16 16:36:07 CST 2024, time=2024-08-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:磁共振;介入;斑块<br>经验分享:技术问题当天回复 一个月内给修改意见 返修以后一周内给结果 proof后4天就在线发表了 不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚见刊,今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快,格式上问题转天就通知修改。杂志偏向介入外科、技术方向,跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回 (专硕临床忙没时间修改到最后截止时间) 5.31 Accept 4个 审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗?<span class="quote">HawkingS 2016-12-14 发表::<br>研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span><span class="quote">HawkingS 2016-12-14 16:34:00 发表:<br>2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天,接收后约15天online<span class="quote">HawkingS 2016-12-14 发表::<br>接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2024-02-03 ms8000001452311796 来自广东省

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:磁共振;介入;斑块
    经验分享:技术问题当天回复 一个月内给修改意见 返修以后一周内给结果 proof后4天就在线发表了 不用版面费

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2220554, encodeId=13ae2220554e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审稿很快,一个月左右一审回来,返修格式问题耽误了几天,返修后3天左右录用,版面费3.5w,也可以选择非OA。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Aug 16 16:36:07 CST 2024, time=2024-08-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:磁共振;介入;斑块<br>经验分享:技术问题当天回复 一个月内给修改意见 返修以后一周内给结果 proof后4天就在线发表了 不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚见刊,今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快,格式上问题转天就通知修改。杂志偏向介入外科、技术方向,跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回 (专硕临床忙没时间修改到最后截止时间) 5.31 Accept 4个 审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗?<span class="quote">HawkingS 2016-12-14 发表::<br>研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span><span class="quote">HawkingS 2016-12-14 16:34:00 发表:<br>2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天,接收后约15天online<span class="quote">HawkingS 2016-12-14 发表::<br>接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2023-06-28 ms5000000862989212

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:刚见刊,今年if跌得也太狠了吧……

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2220554, encodeId=13ae2220554e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审稿很快,一个月左右一审回来,返修格式问题耽误了几天,返修后3天左右录用,版面费3.5w,也可以选择非OA。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Aug 16 16:36:07 CST 2024, time=2024-08-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:磁共振;介入;斑块<br>经验分享:技术问题当天回复 一个月内给修改意见 返修以后一周内给结果 proof后4天就在线发表了 不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚见刊,今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快,格式上问题转天就通知修改。杂志偏向介入外科、技术方向,跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回 (专硕临床忙没时间修改到最后截止时间) 5.31 Accept 4个 审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗?<span class="quote">HawkingS 2016-12-14 发表::<br>研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span><span class="quote">HawkingS 2016-12-14 16:34:00 发表:<br>2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天,接收后约15天online<span class="quote">HawkingS 2016-12-14 发表::<br>接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2022-01-21 N.Yan

    流程很快,格式上问题转天就通知修改。杂志偏向介入外科、技术方向,跟介入治疗、技术不相关的基本一周内就拒了

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2220554, encodeId=13ae2220554e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审稿很快,一个月左右一审回来,返修格式问题耽误了几天,返修后3天左右录用,版面费3.5w,也可以选择非OA。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Aug 16 16:36:07 CST 2024, time=2024-08-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:磁共振;介入;斑块<br>经验分享:技术问题当天回复 一个月内给修改意见 返修以后一周内给结果 proof后4天就在线发表了 不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚见刊,今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快,格式上问题转天就通知修改。杂志偏向介入外科、技术方向,跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回 (专硕临床忙没时间修改到最后截止时间) 5.31 Accept 4个 审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗?<span class="quote">HawkingS 2016-12-14 发表::<br>研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span><span class="quote">HawkingS 2016-12-14 16:34:00 发表:<br>2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天,接收后约15天online<span class="quote">HawkingS 2016-12-14 发表::<br>接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2021-06-01 183431125am

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回 (专硕临床忙没时间修改到最后截止时间) 5.31 Accept 4个 审稿专家意见都很中肯

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2220554, encodeId=13ae2220554e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审稿很快,一个月左右一审回来,返修格式问题耽误了几天,返修后3天左右录用,版面费3.5w,也可以选择非OA。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Aug 16 16:36:07 CST 2024, time=2024-08-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:磁共振;介入;斑块<br>经验分享:技术问题当天回复 一个月内给修改意见 返修以后一周内给结果 proof后4天就在线发表了 不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚见刊,今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快,格式上问题转天就通知修改。杂志偏向介入外科、技术方向,跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回 (专硕临床忙没时间修改到最后截止时间) 5.31 Accept 4个 审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗?<span class="quote">HawkingS 2016-12-14 发表::<br>研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span><span class="quote">HawkingS 2016-12-14 16:34:00 发表:<br>2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天,接收后约15天online<span class="quote">HawkingS 2016-12-14 发表::<br>接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2021-12-28 msSSSSSD

    qPCR的结果如何处理?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2220554, encodeId=13ae2220554e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审稿很快,一个月左右一审回来,返修格式问题耽误了几天,返修后3天左右录用,版面费3.5w,也可以选择非OA。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Aug 16 16:36:07 CST 2024, time=2024-08-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:磁共振;介入;斑块<br>经验分享:技术问题当天回复 一个月内给修改意见 返修以后一周内给结果 proof后4天就在线发表了 不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚见刊,今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快,格式上问题转天就通知修改。杂志偏向介入外科、技术方向,跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回 (专硕临床忙没时间修改到最后截止时间) 5.31 Accept 4个 审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗?<span class="quote">HawkingS 2016-12-14 发表::<br>研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span><span class="quote">HawkingS 2016-12-14 16:34:00 发表:<br>2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天,接收后约15天online<span class="quote">HawkingS 2016-12-14 发表::<br>接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2021-12-27 衣谷

    我的结果中有视频结果可以么?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2220554, encodeId=13ae2220554e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审稿很快,一个月左右一审回来,返修格式问题耽误了几天,返修后3天左右录用,版面费3.5w,也可以选择非OA。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Aug 16 16:36:07 CST 2024, time=2024-08-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:磁共振;介入;斑块<br>经验分享:技术问题当天回复 一个月内给修改意见 返修以后一周内给结果 proof后4天就在线发表了 不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚见刊,今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快,格式上问题转天就通知修改。杂志偏向介入外科、技术方向,跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回 (专硕临床忙没时间修改到最后截止时间) 5.31 Accept 4个 审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗?<span class="quote">HawkingS 2016-12-14 发表::<br>研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span><span class="quote">HawkingS 2016-12-14 16:34:00 发表:<br>2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天,接收后约15天online<span class="quote">HawkingS 2016-12-14 发表::<br>接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2019-09-03 zmc217

    请问下收版面费吗?HawkingS 2016-12-14 发表::
    研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。
    HawkingS 2016-12-14 16:34:00 发表:
    2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。

    HawkingS 2016-12-14 发表:: 研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2220554, encodeId=13ae2220554e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审稿很快,一个月左右一审回来,返修格式问题耽误了几天,返修后3天左右录用,版面费3.5w,也可以选择非OA。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Aug 16 16:36:07 CST 2024, time=2024-08-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:磁共振;介入;斑块<br>经验分享:技术问题当天回复 一个月内给修改意见 返修以后一周内给结果 proof后4天就在线发表了 不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚见刊,今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快,格式上问题转天就通知修改。杂志偏向介入外科、技术方向,跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回 (专硕临床忙没时间修改到最后截止时间) 5.31 Accept 4个 审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗?<span class="quote">HawkingS 2016-12-14 发表::<br>研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span><span class="quote">HawkingS 2016-12-14 16:34:00 发表:<br>2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天,接收后约15天online<span class="quote">HawkingS 2016-12-14 发表::<br>接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2016-12-14 HawkingS2832

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2220554, encodeId=13ae2220554e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审稿很快,一个月左右一审回来,返修格式问题耽误了几天,返修后3天左右录用,版面费3.5w,也可以选择非OA。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Aug 16 16:36:07 CST 2024, time=2024-08-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:磁共振;介入;斑块<br>经验分享:技术问题当天回复 一个月内给修改意见 返修以后一周内给结果 proof后4天就在线发表了 不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:刚见刊,今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快,格式上问题转天就通知修改。杂志偏向介入外科、技术方向,跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回 (专硕临床忙没时间修改到最后截止时间) 5.31 Accept 4个 审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗?<span class="quote">HawkingS 2016-12-14 发表::<br>研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span><span class="quote">HawkingS 2016-12-14 16:34:00 发表:<br>2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 研究方向:外科; 接收率:约50% 审稿时间:约1个月 SCI(2015):2.959 SCI(2014):2.774 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天,接收后约15天online<span class="quote">HawkingS 2016-12-14 发表::<br>接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。</span>, beContent=HawkingS 2016-12-14 发表:: 接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2016-12-14 HawkingS2832

    一审平均22天,接收后约15天onlineHawkingS 2016-12-14 发表::
    接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。

    HawkingS 2016-12-14 发表:: 接收率:约50% 审稿时间:约1个月 2009年创刊后,迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病,包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。

    0

共21条页码: 1/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map